top of page

biologit News

Finalist for the STEM Champion Award at this year's Diversity in Tech Awards

Finalist for the STEM Champion Award at this year's Diversity in Tech Awards

We are happy to announce that our CEO, Nicole Baker, has been shortlisted as a finalist for the STEM Champion Award at this year's Diversity in Tech Awards, in partnership with J.P. Morgan!

Biologit is one of 4 European winners of the UK’s Unicorn Kingdom: Pathfinder Awards.

Biologit is one of 4 European winners of the UK’s Unicorn Kingdom: Pathfinder Awards.

This is the UK Government’s first global tech awards to unearth and showcase promising scale-up companies in the tech industry.

Biologit achieves ISO 27001 certification (information security)

Biologit achieves ISO 27001 certification (information security)

Biologit has obtained certification on the rigorous ISO 27001 information security standard.

To achieve ISO 27001 certification biologit has implemented robust processes and controls to manage and protect information assets effectively across the organisation. With this milestone we continue to demonstrate our commitment to high security standards and being a trusted partner to our customers with our unique literature monitoring platform and service solutions.

Biologit at Medtech Connect

Biologit at Medtech Connect

Our CTO, Bruno Ohana will be speaking at the Medtech Rising conference, as part of MedTech Connect, happening on the 7th of December 2023 at the The Galmont Hotel, Galway, Ireland.

Medtech Connect is a showcase that provides Medtech SMEs a platform to raise awareness and exhibit their innovative technology solutions and business models to potential business partners, large MNCs or investors.

Biologit: Machine learning and AI to monitor medical literature

Biologit: Machine learning and AI to monitor medical literature

Ciologit is featured in Silicon Republic in the article “Machine learning and AI to monitor medical literature”, where co-founders Nicole Baker and Bruno Ohana discuss how the company is meeting the challenges of automating medical literature monitoring for pharmacovigilance and safety surveillance of medical devices, cosmetics and nutraceuticals.

bottom of page